We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+65.87%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$173M
AUM Growth
+$66.8M
Cap. Flow
+$6.73M
Cap. Flow %
3.89%
Top 10 Hldgs %
92.77%
Holding
19
New
1
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$491K
2
APLT
Applied Therapeutics
APLT
+$342K

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 91.2%
2 Materials 1.63%
3 Financials 1.3%
4 Communication Services 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$62.1M 35.84%
857,494
– –
CRBP icon
2
Corbus Pharmaceuticals
CRBP
$170M
$42.3M 24.44%
168,196
– –
APLT
3
DELISTED
Applied Therapeutics
APLT
$23M 13.27%
650,238
+8,167
+1% +$342K
ABEO icon
4
Abeona Therapeutics
ABEO
$345M
$8.15M 4.71%
114,391
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$5.06M 2.92%
17,508
+1,667
+11% +$491K
AVXL icon
6
Anavex Life Sciences
AVXL
$222M
$3.62M 2.09%
724,205
– –
XCUR icon
7
Exicure
XCUR
$11.2M
$3.07M 1.77%
8,519
– –
ENTX icon
8
Entera Bio
ENTX
$101M
$3.01M 1.74%
1,741,363
– –
ALDX icon
9
Aldeyra Therapeutics
ALDX
$91.7M
$2.37M 1.37%
569,405
– –
BX icon
10
Blackstone
BX
$104B
$2.25M 1.3%
40,000
-40,000
-50% -$2.11M
LUMN icon
11
Lumen
LUMN
$6.53B
$2.17M 1.25%
220,000
– –
SNGX icon
12
Soligenix
SNGX
$5.5M
$1.58M 0.91%
3,286
– –
MTEM
13
DELISTED
Molecular Templates, Inc.
MTEM
$1.54M 0.89%
7,594
– –
DOW icon
14
Dow Inc
DOW
$21.6B
$1.22M 0.71%
30,000
– –
OTRK
15
DELISTED
Ontrak
OTRK
$1.1M 0.63%
478
– –
BTAI icon
16
BioXcel Therapeutics
BTAI
$26.2M
$1.07M 0.62%
1,250
– –
CTVA icon
17
Corteva
CTVA
$59.7B
$811K 0.47%
30,000
– –
DD icon
18
DuPont de Nemours
DD
$18.6B
$785K 0.45%
11,950
– –

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Knoll Capital Management held 19 positions worth $173M, up 63% from $106M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Knoll Capital Management deployed $6.73M of net new capital in Q2 2020, opening 1 new position and adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 93% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Blackstone, an estimated $2.11M trimmed.

  • Knoll Capital Management added most to Eiger BioPharmaceuticals, Inc. in Q2 2020, an estimated $491K increase.
  • Knoll Capital Management's biggest Q2 2020 reduction was Blackstone, cutting an estimated $2.11M.
  • Knoll Capital Management's ten largest holdings make up 93% of its $173M portfolio in Q2 2020.
  • Knoll Capital Management opened 1 new position and closed 0 in Q2 2020.
  • Knoll Capital Management's portfolio value rose 63% quarter-over-quarter to $173M.

Based on Knoll Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.